Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMICI: MPC in STEMI
NCT01781390Phase 2Completed
- Sponsor
- Mesoblast Ltd
- Start
- Mar 2013
- Primary completion
- Apr 2021
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of rexlemestrocel-l in ST elevation myocardial infarction (STEMI), sponsored by Mesoblast Ltd. Started Mar 2013; status: completed.
02
Drugs
rexlemestrocel-l
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01781390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01781390.